T 1065/18 of 30.01.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T106518.20230130
- Date of decision
- 30 January 2023
- Case number
- T 1065/18
- Petition for review of
- -
- Application number
- 10167344.0
- IPC class
- C07D 277/56A61P 19/06A61K 31/425
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Polymorphs of Febuxostat
- Applicant name
- SANDOZ AG
- Opponent name
- Alfred E. Tiefenbacher (GmbH & Co. KG)
Teva Pharmaceutical Industries Ltd - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 84European Patent Convention R 103(1)(a)Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Clarity
Inventive step - try and see situation, bonus effect
Reimbursement of appeal fee
Substantial procedural violation - appealed decision reasoned
Late-filed evidence - submitted with the statement of grounds of appeal
Late-filed evidence - submitted shortly before oral proceedings - Catchword
- -
- Citing cases
- T 2086/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.